Investor Overview

Corporate Profile
ContraFect Corporation is a biotechnology company focused on discovering and developing therapeutic protein and antibody products for life-threatening, drug-resistant infectious diseases, particularly those treated in hospital settings. Due to drug-resistant and newly emerging pathogens, hospital acquired infections are currently the fourth leading cause of death in the United States, following heart disease, cancer and stroke. We intend to address drug-resistant infections using our therapeutic product candidates from our lysin and monoclonal antibody platforms to target conserved regions of either bacteria or viruses (regions that are not prone to mutation).
Stock Quote
ExchangeNASDAQ CM (US Dollar)
Price$2.25
Change (%)0.00 (0.00%)
Volume0
Data as of 08/23/16 3:59 p.m. ET
Minimum 20 minute delay
Refresh quote
Press ReleasesMore >>
DateTitle  
08/09/16ContraFect Announces Second Quarter 2016 Results
YONKERS, NY -- (Marketwired) -- 08/09/16 -- ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) , a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious diseases, today announces results for the second quarter ended June 30, 2016. Subsequent to the end of the second quarter, ContraFect completed an underwritten public offering o... 
 Printer Friendly Version
08/04/16ContraFect Receives Designation as a Small and Medium Enterprise by the European Medicines Agency
YONKERS, NY -- (Marketwired) -- 08/04/16 -- ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious diseases, today announces that it has been granted Small and Medium Enterprise (SME) designation by the European Medicines Agency (EMA). The SME designation was established by EMA to promote innovation... 
 Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever ContraFect Corporation posts new information to the site. Just enter your e-mail address and click Submit.
 
Data provided by Nasdaq. Minimum 15 minutes delayed.
Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS |

Share

X
| E-mail Alerts E-mail Alerts | IR Contacts Contact IR | Financial Tear Sheet Tear Sheet